» Articles » PMID: 35153270

Implications of Glutathione-S Transferase P1 in MAPK Signaling As a CRAF Chaperone: In Memory of Dr. Irving Listowsky

Overview
Specialties Biology
Science
Date 2022 Feb 14
PMID 35153270
Authors
Affiliations
Soon will be listed here.
Abstract

Glutathione-S transferase P1 (GSTP1) is one of the glutathione-S transferase isozymes that belong to a family of phase II metabolic isozymes. The unique feature of GSTP1 compared with other GST isozymes is its relatively high expression in malignant tissues. Thus, clinically, GSTP1 serves as a tumor marker and as a refractory factor against certain types of anticancer drugs through its primary function as a detoxifying enzyme. Additionally, recent studies have identified a chaperone activity of GSTP1 involved in the regulation the function of various intracellular proteins, including factors of the growth signaling pathway. In this review, we will first describe the function of GSTP1 and then extend the details onto its role in the mitogen-activated protein kinase signal pathway, referring to the results of our recent study that proposed a novel autocrine signal loop formed by the CRAF/GSTP1 complex in mutated KRAS and BRAF cancers. Finally, the possibilities of new therapeutic approaches for these cancers by targeting this complex will be discussed.

Citing Articles

Upregulation of GSTP1 mediated by chimeric TFE3 promotes TFE3-tRCC progression by targeting JNK signaling pathway.

Chen W, Wu M, Du L, Fang C, Wang H, Wang W World J Surg Oncol. 2024; 22(1):352.

PMID: 39736746 PMC: 11687006. DOI: 10.1186/s12957-024-03633-w.


SPAG6 overexpression decreases the pro-apoptotic effect of daunorubicin in acute myeloid leukemia cells through the ROS/JNK MAPK axis in a GSTP1-dependent manner.

Luo J, Ding L, Pan S, Luo J, Zhao H, Yin J Front Pharmacol. 2024; 15:1390456.

PMID: 39508041 PMC: 11537985. DOI: 10.3389/fphar.2024.1390456.


Superior cuproptotic efficacy of diethyldithiocarbamate-CuO nanoparticles over diethyldithiocarbamate-CuO nanoparticles in metastatic hepatocellular carcinoma.

Abu-Serie M, Barakat A, Ramadan S, Habashy N Front Pharmacol. 2024; 15:1388038.

PMID: 39076585 PMC: 11284037. DOI: 10.3389/fphar.2024.1388038.


Evolving Strategies for Use of Phytochemicals in Prevention and Long-Term Management of Cardiovascular Diseases (CVD).

Haines D, Cowan F, Tosaki A Int J Mol Sci. 2024; 25(11).

PMID: 38892364 PMC: 11173167. DOI: 10.3390/ijms25116176.


Efficient Adsorption and Extraction of Glutathione S-Transferases with Glutathione-Functionalized Graphene Oxide-Polyhedral Oligomeric Silsesquioxane Composite.

Sun J, Jia L, Chen X Molecules. 2023; 28(1).

PMID: 36615535 PMC: 9821976. DOI: 10.3390/molecules28010340.

References
1.
Lu H, Zhou Q, He J, Jiang Z, Peng C, Tong R . Recent advances in the development of protein-protein interactions modulators: mechanisms and clinical trials. Signal Transduct Target Ther. 2020; 5(1):213. PMC: 7511340. DOI: 10.1038/s41392-020-00315-3. View

2.
Ritchie K, Henderson C, Wang X, Vassieva O, Carrie D, Farmer P . Glutathione transferase pi plays a critical role in the development of lung carcinogenesis following exposure to tobacco-related carcinogens and urethane. Cancer Res. 2007; 67(19):9248-57. DOI: 10.1158/0008-5472.CAN-07-1764. View

3.
Kun E, Tsang Y, Ng C, Gershenson D, Wong K . MEK inhibitor resistance mechanisms and recent developments in combination trials. Cancer Treat Rev. 2020; 92:102137. DOI: 10.1016/j.ctrv.2020.102137. View

4.
Takayama T, Nagashima H, Maeda M, Nojiri S, Hirayama M, Nakano Y . Randomized double-blind trial of sulindac and etodolac to eradicate aberrant crypt foci and to prevent sporadic colorectal polyps. Clin Cancer Res. 2011; 17(11):3803-11. DOI: 10.1158/1078-0432.CCR-10-2395. View

5.
Oakley A . Glutathione transferases: a structural perspective. Drug Metab Rev. 2011; 43(2):138-51. DOI: 10.3109/03602532.2011.558093. View